Tiffany Kaul
la Jolla, CANPI 1669050514
Payments from drug & device makers
Across 62 payments — averaging $27.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AVEO Pharmaceuticals, Inc.$340
- AstraZeneca$167
- Sobi, Inc$147
- Johnson & Johnson$135
- GSK$106
- Novartis$87
- plus $725 from 21 others
What the payments were for
- Food & beverage$1,52689%
- Education$18011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AVEO Pharmaceuticals, Inc. | 6 | $340 |
| AstraZeneca(2 entities) | 7 | $167 |
| Sobi, Inc | 6 | $147 |
| Johnson & Johnson | 4 | $135 |
| GSK | 5 | $106 |
| Novartis | 3 | $87 |
| Genentech USA, Inc. | 4 | $87 |
| AbbVie | 3 | $71 |
| Eisai Inc. | 3 | $70 |
| Merck | 3 | $63 |
| Servier Pharmaceuticals LLC | 2 | $39 |
| Dendreon Pharmaceuticals LLC | 1 | $35 |
| Bristol Myers Squibb | 1 | $33 |
| Blueprint Medicines Corporation | 1 | $30 |
| Exelixis Inc. | 1 | $29 |
| Taiho Oncology, Inc. | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Bayer | 1 | $25 |
| Agios Pharmaceuticals, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Array Biopharma Inc | 1 | $23 |
| Incyte Corporation | 1 | $23 |
| Boehringer Ingelheim | 1 | $20 |
| Tempus AI, Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Tersera Therapeutics LLC | 1 | $19 |
| Genmab U.S., Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FOTIVDA$130
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.